ALPL and myocardial infarction: Inhibition of nonspecific alkaline phosphatase (TNAP) suppresses cardiac fibroblast proliferation and myocardial infarction (MI)-induced cardiac fibrosis, which can be abrogated by pfithrin-α, indicating that TNAP inhibitor exerts an anti-fibrotic mechanism partially through p53 [118].